EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genotyping of suspected partial hydatidiform moles – our experiences and future directions

Lajos Gergely, Vanda Repiska, Juraj Hutnik, Natalia Andova, Lubica Milosovicova, Miroslav Korbel, Liam McCullough, Alexandra Kristufkova, Ludovit Danihel, Helena Gbelcova, Petra Priscakova

Pathology & Oncology Research · 25.05.2026 · 32

DOI: 10.3389/pore.2026.1612410 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology & Oncology Research, online erschienen am 25.05.2026. Verfasst von Lajos Gergely und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University Bratislava, Bratislava, Slovakia. Hauptthemen laut MEDLINE: Hydatidiform Mole, Uterine Neoplasms, Microsatellite Repeats. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NextGenerationEU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This brief research report summarizes our experience with the molecular differential diagnosis of clinically or pathologically suspected partial hydatidiform moles and discusses practical diagnostic options when economic resources or laboratory infrastructure are limited. We analyzed the genome composition of 68 suspected cases using short tandem repeat genotyping based on quantitative fluorescent PCR and fragmentation analysis. Genetic testing excluded a partial mole in 35 cases (51%) by demonstrating a diploid or monogynic monoandric diploid genome, while in 33 cases (49%) a partial mole was confirmed through identification of diandric triploidy (31 cases) or triandric tetraploidy (2 cases). No instances of digynic triploidy were detected in this cohort. Our findings indicate that, in the absence of access to a DNA laboratory, most suspected partial moles can still be accurately evaluated using ploidy assessment by more widely available methods, such as fluorescent in situ hybridization, DNA flow cytometry, or conventional karyotyping, given the apparent rarity of digynic triploidy among these cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydatidiform MoleUterine NeoplasmsMicrosatellite RepeatsHumansFemalePregnancyGenotypeIn Situ Hybridization, FluorescenceAdult

Stichwörter der Autor:innen

DNA analysisdiploidygestational trophoblastic diseasepartial hydatidiform moletriploidy

Autor:innen und Institutionen

  • Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University Bratislava, Bratislava, Slovakia.
  • Centre for Gestational Trophoblastic Disease of Slovak Republic, Bratislava, Slovakia.
  • 1st Department of Gynaecology and Obstetrics, Faculty of Medicine, Comenius University Bratislava, Bratislava, Slovakia.
  • Institute of Pathological Anatomy, Faculty of Medicine, Comenius University Bratislava, Bratislava, Slovakia.

Förderung

  • NextGenerationEU

Zitieren

APA

Gergely, L., Repiska, V., Hutnik, J., Andova, N., Milosovicova, L., Korbel, M., McCullough, L., Kristufkova, A., Danihel, L., Gbelcova, H., & Priscakova, P. (2026). Genotyping of suspected partial hydatidiform moles – our experiences and future directions. Pathology & Oncology Research, 32. https://doi.org/10.3389/pore.2026.1612410

Vancouver

Gergely L, Repiska V, Hutnik J, Andova N, Milosovicova L, Korbel M, et al. Genotyping of suspected partial hydatidiform moles – our experiences and future directions. Pathology & Oncology Research. 2026;32. doi:10.3389/pore.2026.1612410

BibTeX
@article{Gergely2026,
  author = {Gergely, Lajos and Repiska, Vanda and Hutnik, Juraj and Andova, Natalia and Milosovicova, Lubica and Korbel, Miroslav and McCullough, Liam and Kristufkova, Alexandra and Danihel, Ludovit and Gbelcova, Helena and Priscakova, Petra},
  title = {Genotyping of suspected partial hydatidiform moles – our experiences and future directions},
  journal = {Pathology & Oncology Research},
  year = {2026},
  volume = {32},
  doi = {10.3389/pore.2026.1612410}
}
Kostenlos starten →